Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 13, 2023 08:30 ET | Source: Anika Therapeutics Inc.

Anika Announces First Surgeries Performed Using the New RevoMotion™ Reverse Shoulder Arthroplasty System and Commences Limited Market Release in the United States

RevoMotion significantly expands Anika’s shoulder arthroplasty portfolio and provides a new solution in the over $800 million U.S. reverse shoulder market RevoMotion offers the industry’s smallest...
November 08, 2022 16:05 ET | Source: Anika Therapeutics Inc.

Anika Reports Third Quarter Fiscal 2022 Financial Results

Third Quarter Revenue Growth of 2% Third Phase III Clinical Trial for Cingal®, Next Generation Osteoarthritis Pain Product, Achieved Primary Endpoint Demonstrating Superiority Over Steroid Alone ...
November 01, 2022 08:00 ET | Source: Anika Therapeutics Inc.

Anika’s Cingal® Successfully Achieves Primary Endpoint in Third Phase III Study

Study Demonstrated Superiority of Cingal, a Single-Injection Hyaluronic Acid-Based Viscosupplement Combined with Fast-Acting Steroid, Over Steroid Alone, for Osteoarthritis Pain Relief at 26 Weeks ...
October 25, 2022 09:25 ET | Source: Anika Therapeutics Inc.

Anika to Issue Third Quarter 2022 Financial Results on Tuesday, November 8, 2022

BEDFORD, Mass., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
September 12, 2022 16:01 ET | Source: Anika Therapeutics Inc.

Anika Announces First Surgeries Performed Using the X-Twist™ Fixation System and Commences Limited Market Release

BEDFORD, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced the limited...
August 03, 2022 16:05 ET | Source: Anika Therapeutics Inc.

Anika Reports Second Quarter Fiscal 2022 Financial Results

Second quarter revenue growth up 4%X-Twist™ 510(k) clearance received; Limited market release on schedule for 2H 2022 BEDFORD, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc....
July 27, 2022 09:15 ET | Source: Anika Therapeutics Inc.

Anika Receives the ACE Award for Cutting-Edge Innovation for Tactoset® Injectable Bone Substitute from the American Orthopedic Society for Sports Medicine

BEDFORD, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has...
July 12, 2022 17:05 ET | Source: Anika Therapeutics Inc.

Anika to Issue Second Quarter 2022 Financial Results on Wednesday, August 3, 2022

BEDFORD, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company...
June 10, 2022 09:27 ET | Source: Anika Therapeutics Inc.

Anika to Participate in the Sidoti Small Cap Virtual Investor Conference

BEDFORD, Mass., June 10, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...
May 20, 2022 07:00 ET | Source: Anika Therapeutics Inc.

Anika Receives FDA 510(k) Clearance for the X-Twist™ Knotless Fixation System, Expanding its Sports Medicine Soft Tissue Portfolio

BEDFORD, Mass., May 20, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that it has...